the journal of Pharmacy Technology the journal of Pharmacy Technology
Abstracts of Back Issues
Home
Home
Receive the Table of Contents by E-mail
Back Issues
Author Information
PharmaCE
Acknowledgments
About the journal
Order Form
Customer Service
Advertising Information
Contact Information


Use of Low-Molecular-Weight Heparin for the Treatment of Venous Thromboembolism in Patients with Cancer: A Review of the Literature

Jamie M Pitlick, Andrew J Crannage, and Julie A Murphy

To request full article click here.

Objective: To evaluate the literature on use of low-molecular-weight heparin (LMWH) for the treatment of venous thromboembolism (VTE) in patients with cancer for the first 3–6 months of anticoagulant therapy.

Data Sources: A preliminary literature search of PubMed (1966–May 2009) was performed, using the MeSH database when possible, with the terms venous thromboembolism, venous thrombosis, pulmonary embolism, neoplasm, vitamin K antagonist, and low-molecular-weight heparin. Bibliographies of all articles retrieved were also reviewed.

Study Selection and Data Extraction: All studies published in English with data describing the safety and/or efficacy of LMWH in subjects with cancer for the first 3–6 months of anticoagulant therapy for VTE were included.

Data Synthesis: Five studies that met the above criteria were identified. When compared with vitamin K antagonists, LMWH therapy decreased recurrent VTE in subjects with cancer. Many of these studies had important limitations, including open-label design, relatively short duration, ineffective LMWH dosing, and small sample size.

CONCLUSIONS: The studies analyzed support the American College of Chest Physicians Evidence-Based Clinical Practice Guidelines’ recommendation for the use of LMWH for the first 3–6 months of anticoagulant therapy for VTE in patients with cancer. Specifically, in clinical trials, tinzaparin and dalteparin have demonstrated increased efficacy compared with vitamin K antagonists.

J Pharm Technol 2009;25:244-9.
ACPE Universal Program Number: 407-000-09-055-H01-P (Pharmacists)

To request full article click here.


Harvey Whitney Books


Harvey Whitney Books

 
 

the journal of Pharmacy Technology
is published by HARVEY WHITNEY BOOKS COMPANY
8044 Montgomery Road, Suite 415, Cincinnati, OH 45236-2919
P.O. Box 42696, Cincinnati, OH 45242-0696 USA
Tel. 513/793-3555, FAX 513/793-3600
Office Hours: 9-5 E.S.T.
Contact Information
All Rights Reserved. Copyright © 1998-